MBMaría Gemma Millán de la Blanca

María Gemma Millán de la Blanca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


María Gemma Millán de la Blanca has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deciphering embryo-maternal cross-talk: advanced in vitro approaches

    by Gislaine dos Santos, María Gemma Millán de la Blanca, Yulia Nathaly Cajas, Rosane Mazzarella, Karina Cañón-Beltrán, Maria Encina Gonzalez Martínez, Dimitrios Rizos

    Embryo-maternal communication is a critical process that influences early embryonic development, implantation success, and pregnancy outcomes across mammalian species. This review examines the diverse in vitro systems developed to study this complex dialogue, highlighting their applications, advantages, and limitations. We explore conventional approaches such as two-dimensional (2D) cell cultures, which despite their simplicity, face challenges in replicating the three-dimensional (3D) architecture and cellular functions present in vivo. The review progresses through increasingly sophisticated models, including fluid co-culture systems that incorporate bioactive molecules, explant cultures that maintain tissue architecture, air-liquid interface systems that promote epithelial polarization and differentiation, 3D organoid systems that recapitulate complex structural organization, and organ-on-a-chip platforms that recreate mechanical forces and dynamic conditions. Special attention is given to the emerging role of extracellular vesicles (EVs) as mediators of embryo-maternal communication, transporting crucial molecular signals between the embryo and reproductive tract. By comparing these systems across species and developmental stages, we provide a comprehensive framework for selecting appropriate models based on specific research questions. The integration of these in vitro approaches with advanced analytical techniques offers promising avenues for understanding embryo-maternal cross-talk, potentially leading to improved assisted reproductive technologies and strategies to mitigate early pregnancy loss. As technology advances, the continued refinement of these systems will further illuminate the intricate molecular and cellular mechanisms underlying successful embryo development and implantation.


  • Resveratrol–cyclodextrin complex affects the expression of genes associated with lipid metabolism in bovine in vitro produced embryos

    by V Torres, M Hamdi, Mg Millán de la Blanca, R Urrego, J Echeverri, A López‐Herrera, D Rizos, A Gutiérrez‐Adán, Mj Sánchez‐Calabuig

    Contents: Antioxidants have been widely used during in vitro production to decrease the negative effect of reactive oxygen species. It was reported that the complex resveratrol–methyl β‐cyclodextrin (RV‐CD) improves resveratrol's stability and bioavailability and increases its antioxidant activity. This study evaluates the effect of RV‐CD during in vitro oocyte maturation (IVM) or in vitro embryo culture (IVC) on developmental competence and quantitative changes in gene expression of developmental important genes. In experiment 1, RV‐CD was added to IVM media and maturation level, embryo development and oocytes, cumulus cells, and blastocysts gene expression by RT‐qPCR were examined. In experiment 2, presumptive zygotes were cultured in SOF supplemented with RV‐CD and embryo development and blastocysts gene expression by RT‐qPCR were studied. A group without RV‐CD (control−) and a group with cyclodextrin (control+) were included. No differences were found in cleavage rate or blastocyst yield between groups. However, the expression of LIPE was higher in blastocysts derived from oocytes treated with resveratrol compared with control groups (p < .05). Blastocysts produced by IVC with resveratrol showed that RV‐CD could modify the expression of genes related to lipid metabolism (CYP51A1, PNPLA2 and MTORC1) compared with control groups (p < .05). RV‐CD in the IVM and IVC media could reduce accumulated fat by increasing lipolysis and suppressing lipogenesis of blastocysts.